#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema Mantle cell lymphoma stage III Ocular lymphoma Laryngeal squamous cell carcinoma Pleural mesothelioma malignant Metabolic disorder Retinitis pigmentosa Chronic lymphocytic leukaemia refractory Gastrooesophageal cancer Chronic graft versus host disease Paraneoplastic neurological syndrome Neuroblastoma Diffuse large B-cell lymphoma Choroidal dystrophy Uterine leiomyosarcoma More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Marginal zone lymphoma refractory – Diagnostics Niemann-Pick disease – Trials in Disease Haemophilia – Basic Information Idiopathic pulmonary fibrosis – Life with Disease Primary biliary cholangitis – Basic Information Biotinidase deficiency – Trials in Disease Erdheim-Chester disease – Basic Information Myxofibrosarcoma – Trials in Disease Angiosarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ROPINIROLE NVG-2089 Calcitriol ANOC-001 Emraclidine INSULIN DETEMIR Iopromide Cldn6 Car-T(A) Cefuroxime Hydroxypropyl Cellulose Lf ATTR-01 Norfloxacin Murcidencel Abacavir Hexaminolevulinate Alglucosidase Alfa Ganciclovir Rosuvastatin Calcium Mavorixafor Darunavir More therapies…

    Learn about Your Condition

    Neonatal asphyxia Myxofibrosarcoma Hereditary ataxia Liver transplant rejection Bacterial prostatitis Ichthyosis Cardiovascular disorder Adrenoleukodystrophy Autoimmune uveitis Becker's muscular dystrophy Osteoporosis postmenopausal Schizophreniform disorder Urticaria cholinergic Subarachnoid haemorrhage Encephalopathy neonatal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Victor Dupouy

Centre Hospitalier Victor Dupouy

69 Rue Du Lieutenant Colonel Prudhon, Argenteuil, 95107, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of ustekinumab, adalimumab, and baricitinib for patients with folliculitis decalvans that is difficult to treat

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Baricitinib
    • Adalimumab
    • Ustekinumab
    France

  • Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Caspofungin
    • Fluconazole
    • Anidulafungin
    France

  • Testing rasburicase for preventing and treating kidney problems in adult patients with sepsis and high uric acid levels

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Rasburicase
    France

  • Study of pirtobrutinib combined with immuno-chemotherapy for previously untreated patients with symptomatic chronic lymphocytic leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Pirtobrutinib
    France

  • Study on Etoposide for Patients with Severe Hemophagocytic Lymphohistiocytosis in Intensive Care

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Etoposide
    France

  • Study Comparing Different Antibiotic Treatments for ICU Patients with Hospital-Acquired Sepsis: Focus on Cefepime and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Ceftolozane
    • Meropenem
    • Cefepime Hydrochloride
    France

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    • Carfilzomib
    • Dexamethasone
    Belgium France

  • Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Cholesterol
    • Sphingomyelin (Egg)
    • Sodium Chloride
    Belgium Czechia France Greece Hungary Latvia +3

  • Study of inhaled interferon beta-1a (SNG001) for treatment of patients with viral lower respiratory tract infections who require mechanical ventilation

    Not recruiting

    2 1
    Investigated Drugs:
    • Interferon Beta-1A
    Belgium France The Netherlands Spain

  • Study on the Effectiveness of Enasidenib Mesilate in Patients with Myelodysplastic Syndrome with IDH2 Mutation

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Enasidenib Mesilate
    France Germany
Previous Page
1 … 3 4 5 6 7 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!